These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11321935)

  • 1. Liver disease and diabetes mellitus.
    Baig NA; Herrine SK; Rubin R
    Clin Lab Med; 2001 Mar; 21(1):193-207. PubMed ID: 11321935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted associations of hepatobiliary disease and diabetes.
    Bell DS; Allbright E
    Endocr Pract; 2007; 13(3):300-12. PubMed ID: 17599864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients.
    Rosenkranz B
    Horm Metab Res; 1996 Sep; 28(9):434-9. PubMed ID: 8911979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic liver diseases and diabetes].
    Jaafar J; de Kalbermatten B; Philippe J; Scheen A; Jornayvaz FR
    Rev Med Suisse; 2014 Jun; 10(433):1254, 1256-60. PubMed ID: 25004772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione hepatotoxicity: a class effect?
    Tolman KG
    Int J Clin Pract Suppl; 2000 Oct; (113):29-34. PubMed ID: 11965828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acarbose-induced hepatic injury.
    Fujimoto Y; Ohhira M; Miyokawa N; Kitamori S; Kohgo Y
    Lancet; 1998 Jan; 351(9099):340. PubMed ID: 9652620
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis].
    Kalmykova ZA; Kononenko IV; Mayorov AY
    Ter Arkh; 2019 Oct; 91(10):106-111. PubMed ID: 32598639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.
    Home PD; Pacini G
    Diabetes Obes Metab; 2008 Sep; 10(9):699-718. PubMed ID: 17825080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus in patients with cirrhosis: clinical implications and management.
    Elkrief L; Rautou PE; Sarin S; Valla D; Paradis V; Moreau R
    Liver Int; 2016 Jul; 36(7):936-48. PubMed ID: 26972930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
    Roden M
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
    Balabolkin MI; Nedosugova LV
    Probl Endokrinol (Mosk); 1993; 39(4):16-8. PubMed ID: 8415521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic liver disease in diabetes mellitus.
    Amarapurkar D; Das HS
    Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes mellitus after solid organ transplantation.
    Bodziak KA; Hricik DE
    Transpl Int; 2009 May; 22(5):519-30. PubMed ID: 19040489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease].
    Cotrozzi G; Casini Raggi V; Relli P; Buzzelli G
    Ann Ital Med Int; 1997; 12(2):84-91. PubMed ID: 9333317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrative review: hepatobiliary disease in type 2 diabetes mellitus.
    Tolman KG; Fonseca V; Tan MH; Dalpiaz A
    Ann Intern Med; 2004 Dec; 141(12):946-56. PubMed ID: 15611492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The thiazolidinones--a new therapeutic agent for type 2 diabetes].
    Bethge H; Häring HU
    Arzneimittelforschung; 1998 Feb; 48(2):97-119. PubMed ID: 9541719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
    Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
    Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.